Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- include docetaxelPhase 31 trial
Shanghai Runshi Pharmaceutical Technology Co., Ltd · Advanced Oesophageal Squamous Cell Carcinoma
- INS068Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Type 2 Diabetes
- INT230-6Phase 31 trial
Intensity Therapeutics, Inc. · Sarcoma,Soft Tissue
- Intravitreal RanibizumabPhase 31 trial
Roche (Genentech) · Diabetic Macular Edema
- ION363Phase 31 trial
Ionis Pharmaceuticals · Amyotrophic Lateral Sclerosis
- ipilimumab and nivolumabPhase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
- IPN60340Phase 31 trial
Ipsen · Acute Myeloid Leukaemia (AML), Acute Myeloid Leukaemia
- IptilimumabPhase 31 trial
InSightec · Brain Tumor, Non Small Cell Lung Cancer
- IS-001Phase 31 trial
Intuitive Surgical · Ureter Injury
- IVA337LanifibranorPhase 31 trial
Inventiva Pharma · NASH - Nonalcoholic Steatohepatitis
- JKN2401Phase 31 trial
Joincare Pharmaceutical Group Industry Co., Ltd · Chronic Obstructive Pulmonary Disease (COPD)
- JMKX001899Phase 31 trial
Jemincare · NSCLC (Non-small Cell Lung Cancer)
- JNJ-87189401Phase 31 trial
Johnson & Johnson (Janssen) · Metastatic Castration-resistant Prostatic Neoplasms
- JW0104Phase 31 trial
JW Pharmaceutical · Hypertension, Dyslipidemia
- JW0108Phase 31 trial
JW Pharmaceutical · Dyslipidemia
- JX10Phase 31 trial
Corxel Pharmaceuticals · Acute Ischemic Stroke
- JYP0035Phase 31 trial
Chengdu JOYO pharma Co., Ltd. · Breast Cancer
- JZP926Phase 31 trial
Jazz Pharmaceuticals · Juvenile Myoclonic Epilepsy
- KB803Phase 31 trial
Krystal Biotech, Inc. · Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa
- KK8398Phase 31 trial
Kyowa Kirin Co., Ltd. · Achondroplasia
- KP-001Phase 31 trial
Kaken Pharmaceutical · Venous Malformations, Lymphatic Malformations, Klippel-Trenaunay Syndrome
- KP-100ITPhase 31 trial
Kringle Pharma, Inc. · Acute Spinal Cord Injury (SCI)
- KP-100LIHepatocyte Growth Factor, HGFPhase 31 trial
Kringle Pharma, Inc. · Vocal Fold Scar
- KPS-0373Phase 31 trial
Kissei Pharmaceutical Co., Ltd. · Spinocerebellar Degeneration
- L606Treprostinil LiposomePhase 31 trial
Liquidia Technologies, Inc. · Pulmonary Hypertension Due to Lung Disease (Disorder)
- Larazotide AcetatePhase 31 trial
Interlude Biopharma Co. · Celiac Disease, Celiac Disease in Adolescents
- LerotinibZ650Phase 31 trial
Sunshine Lake Pharma Co., Ltd. · Esophageal Cancer
- LevilimabPhase 31 trial
Biocad · Rheumatoid Arthritis
- LibevitugPhase 31 trial
Huahui Health · Chronic Hepatitis D Infection
- licaminlimabPhase 31 trial
Oculis · Dry Eye Disease (DED)
- LID104Phase 31 trial
EMS · Type 2 Diabetes Mellitus
- LMN-201Phase 31 trial
Lumen Bioscience, Inc. · Clostridioides Difficile Infection
- LNS8801Phase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
- LW402Phase 31 trial
Shanghai Longwood Biopharmaceuticals Co., Ltd. · Moderate to Severe Atopic Dermatitis
- LY01015Phase 31 trial
Shandong Boan Biotechnology Co., Ltd · Esophageal Squamous Cell Carcinoma
- LYB005Phase 31 trial
Guangzhou Patronus Biotech Co., Ltd. · Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine
- LYR-210Phase 31 trial
Lyra Therapeutics · Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)
- LZM012Phase 31 trial
Livzon Pharmaceutical Group Inc. · Psoriasis
- M701Phase 31 trial
Wuhan YZY Biopharma Co., Ltd. · Malignant Ascites
- matched to CagrilintidePhase 31 trial
Novo Nordisk · Overweight, Obesity, Type 2 Diabetes
- matched to PovetaciceptPhase 31 trial
Alpine Immune Sciences Inc, A Subsidiary of Vertex · Immunoglobulin A Nephropathy
- MB11Proposed Nivolumab BiosimilarPhase 31 trial
mAbxience Research S.L. · Advanced (Unresectable or Metastatic) Melanoma
- MB12Proposed Pembrolizumab BiosimilarPhase 31 trial
mAbxience Research S.L. · Non Squamous Non Small Cell Lung Cancer
- MDR-001Phase 31 trial
MindRank AI Ltd · Overweight or Obesity
- MLC 901Phase 31 trial
Moleac Pte Ltd. · Alzheimer's Disease Dementia
- MN-166ibudilastPhase 31 trial
MediciNova · Amyotrophic Lateral Sclerosis
- MolnupiravirMK-4482, LAGEVRIOPhase 31 trial
Merck & Co. · Coronavirus Disease (COVID-19)
- MR-100A-01Transdermal contraceptive delivery systemPhase 31 trial
Mylan Technologies Inc. · Contraception
- MR-107A-02Phase 31 trial
Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain
- MRG002Phase 31 trial
Shanghai Miracogen Inc. · Advanced or Metastatic Urothelium Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.